A placebo is a treatment that looks like the real thing (a pill, injection, or other therapy), but doesn’t contain any active medical ingredients. Think of it as a “sugar pill” it’s not meant to treat your condition directly, but it’s used in clinical research for a very important reason. Sometimes, especially for non-drug interventions, you may hear the term “sham” used instead of placebo. A sham is a procedure or device that mimics the real treatment but lacks the active component, helping researchers measure the true effect of the intervention.
Placebos help researchers determine whether a new treatment actually works. By comparing the group that gets the new drug to a group that gets a placebo, scientists can see if the medicine has a real benefit.
For example, if a new drug is being tested for migraine relief, half the participants might get the real drug, and the other half might get a placebo. If the people who took the real drug improve significantly more than those who took the placebo, researchers can be more confident the treatment is effective.
As a patient, your health and well-being are top priorities. That’s why it’s so important to ask: Is it ethical to give someone a placebo instead of actual treatment?
According to the World Medical Association's Declaration of Helsinki, placebos can only be used in research when no proven treatment exists—or when withholding treatment will not cause harm.
Placebos should not be used if:
This is why informed consent is so important. When you agree to join a trial, you must receive all the information you need to make the best choice for your health.
If you’re joining a trial and there’s a chance you’ll receive a placebo, you deserve to know:
You always have the right to ask questions before participating.
In clinical trials, when it is not ethical or feasible to use a placebo—especially in cases involving serious or life-threatening conditions—the experimental treatment is typically compared to the Standard of Care (SoC). The Standard of Care refers to the best-known and widely accepted current treatment for a specific condition. This approach ensures that all participants receive some form of effective therapy, aligning with ethical standards that prioritize patient well-being.
Comparing a new treatment to the SoC allows researchers to assess whether the new intervention offers added benefits in terms of efficacy, safety, or tolerability. This design is commonly used in Phase III trials and in therapeutic areas like oncology, cardiology, and infectious diseases where withholding treatment could be harmful. In summary, when placebos are not appropriate, the Standard of Care serves as the ethical and scientific benchmark for evaluating new medical interventions.
Before enrolling, ask:
The more informed you are, the more empowered you’ll be to make the right decision.
As a patient, your rights and well-being come first. The use of placebos in clinical research raises important ethical questions, but when used responsibly and ethically, they can lead to medical breakthroughs that benefit everyone.
At Patlynk, we understand how overwhelming it can be to navigate clinical trials. That’s why we’re here to make it easier for you. We help connect patients like you to ethical, approved, and monitored clinical trials that prioritize safety and transparency.
Whether you’re seeking new treatment options or just curious about how trials work, Patlynk is your trusted partner in exploring these opportunities.